Show
Sort by
-
SOX11 acts as part of the MYCN regulatory protein complex implicated in neuroblastoma
-
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment
-
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment
-
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment
-
Upregulation of MAPK negative feedback regulators and RET in mutant ALK neuroblastoma : implications for targeted treatment
-
ETV5 functionally connect ALK and RET signaling in neuroblastoma
-
SOX11 is a lineage-survival oncogene in neuroblastoma
-
SOX11 is a lineage-survival oncogene in neuroblastoma
-
Characterization of ALK driven molecular networks identifies perturbed RET and cholinergic signaling in neuroblastoma
-
Identification of miRNAs implicated in neuroblastoma tumor initiation and progression through cross-species integrated genomic analysis